Echo-guided left ventricular assist device speed optimisation for exercise maximisation.
Echo-guided left ventricular assist device speed optimisation for exercise maximisation.
复制标题
DOI:
10.1136/heartjnl-2021-320495
复制
发表时间:
2022-06-10
期刊:
影响因子:
5.7
通讯作者:
Wierzbicki, Karol
中科院分区:
文献类型:
--
作者:
Stapor, Maciej;Pilat, Adam;Gackowski, Andrzej;Misiuda, Agnieszka;Gorkiewicz-Kot, Izabela;Kaleta, Michal;Kleczynski, Pawel;Zmudka, Krzysztof;Legutko, Jacek;Kapelak, Boguslaw;Wierzbicki, Karol
Current generation left ventricular assist devices (LVADs) operate with a fixed rotation speed and no automated speed adjustment function. This study evaluates the concept of physiological pump speed optimisation based on aortic valve opening (AVO) imaging during a cardiopulmonary exercise test (CPET). This prospective crossover study (NCT05063006) enrolled patients with implanted third-generation LVADs with hydrodynamic bearing. After resting speed optimisation, patients were randomised to a fixed-modified speed or modified-fixed speed CPET sequence. Fixed speed CPET maintained baseline pump settings. During the modified speed CPET, the LVAD speed was continuously altered to preserve periodic AVO. We included 22 patients, the mean age was 58.4±7 years, 4.5% were women and 54.5% had ischaemic cardiomyopathy. Exertional AVO assessment was feasible in all subjects. Maintaining periodic AVO allowed to safely raise the pump speed from 2900 (IQR 2640–3000) to 3440 revolutions per minute (RPM) (IQR 3100–3700; p<0.001). As a result, peak oxygen consumption increased from 11.1±2.4 to 12.8±2.8 mL/kg/min (p<0.001) and maximum workload from 1.1 (IQR 0.9–1.5) to 1.2 W/kg (IQR 0.9–1.7; p=0.028). The Borg scale exertion level decreased from 15.2±1.5 to 13.5±1.2 (p=0.005). Transthoracic AVO imaging is possible during CPETs in patients with LVAD. Dynamic echo-guided pump speed adjustment based on the AVO improves exercise tolerance and augments peak oxygen consumption and maximum workload.
登录
查看更多内容
影响因子:
8.9
作者:
Jung, Mette Holme;Gustafsson, Finn
通讯作者:
Gustafsson, Finn
DOI:
10.1161/circheartfailure.120.007448
发表时间:
2021-01
期刊:
Circulation. Heart failure
影响因子:
--
作者:
Sailer C;Edelmann H;Buchanan C;Giro P;Babcock M;Swanson C;Spotts M;Schulte M;Pratt-Cordova A;Coe G;Beindorff M;Page RL 2nd;Ambardekar AV;Pal JD;Kohrt W;Wolfel E;Lawley JS;Tarumi T;Cornwell WK 3rd
通讯作者:
Cornwell WK 3rd
影响因子:
8.9
作者:
Loyaga-Rendon, Renzo Y.;Plaisance, Eric P.;Shah, Keyur
通讯作者:
Shah, Keyur
影响因子:
13
作者:
Moss, Noah;Rakita, Val;Mancini, Donna M.
通讯作者:
Mancini, Donna M.
影响因子:
3.7
作者:
Gross, Christoph;Fresiello, Libera;Moscato, Francesco
通讯作者:
Moscato, Francesco